ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

KZR Kezar Life Sciences Inc

0,833
-0,0217 (-2,54%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Kezar Life Sciences Inc KZR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,0217 -2,54% 0,833 01:45:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,86 0,8336 0,86 0,8574 0,8547
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/4/202422:01BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
14/3/202421:01BWKezar Life Sciences Reports Fourth Quarter and Year End 2023..
08/3/202422:05BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
28/2/202422:01BWKezar Life Sciences to Participate in the TD Cowen 44th..
27/2/202400:30BWEverest Medicines and Kezar Life Sciences Receive IND..
14/2/202412:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202423:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:36EDGAR2Form 8-K - Current report
04/12/202322:28EDGAR2Form 8-K - Current report
21/11/202322:01BWKezar Life Sciences to Present at the 6th Annual Evercore..
13/11/202322:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:01BWKezar Life Sciences Reports Third Quarter 2023 Financial..
09/11/202322:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:03BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
27/10/202322:06EDGAR2Form 8-K - Current report
09/10/202323:56BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
03/10/202322:14EDGAR2Form 8-K - Current report
03/10/202322:10BWKezar Life Sciences Announces Strategic Restructuring to..
21/9/202302:30DJNStocks to Watch: FedEx, Kezar Life Sciences, Transcat
21/9/202300:30BWKezar Life Sciences and Everest Medicines Enter into an..
31/8/202322:01BWKezar Life Sciences to Participate in Three Upcoming..
10/8/202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:06EDGAR2Form 8-K - Current report
10/8/202322:01BWKezar Life Sciences Reports Second Quarter 2023 Financial..
04/8/202322:03BWKezar Announces Inducement Grants Under NASDAQ Listing Rule..
26/7/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202322:37EDGAR2Form 8-K - Current report
24/7/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202322:01BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
09/6/202322:01BWKezar Announces Inducement Grants Under NASDAQ Listing Rule..
31/5/202313:00BWKezar Life Sciences to Participate in the Jefferies..
11/5/202322:01BWKezar Life Sciences Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

Delayed Upgrade Clock